Importing Canadian Drugs – Good or Bad?

Most people complain about the price of prescription drugs in our country. That’s why politicians, like former President Donald Trump, current President Joe Biden, and presidential candidate Governor Ron DeSantis all agree on the idea of importing less-expensive drugs from Canada. It seems to make perfectly good sense.

But a closer look can be revealing. The issue is more complicated that these politicians will tell you. By importing prescription drugs from countries with socialized healthcare systems, you are also importing their government price controls.

Last week the Food and Drug Administration approved Florida Governor DeSantis’s request to import drugs from Canada. The Wall Street Journal editors tell us DeSantis pitched the idea in 2019 to lower drug prices, and the Trump Administration teed it up for FDA approval with enabling regulations. “We will finally allow the safe and legal importation of drugs from Canada,” Mr. Trump said in 2020.

With this approval, Governor DeSantis is taking a victory lap. “Canada has the same drugs. They’re like 25 cents on the dollar, and part of that is because of the way their government suppresses the price,” he said in Iowa. “Bottom line is that if I can get 25 cents on the dollar, I can save $100 million, $200 million in Florida.”

Full disclosure, I have been a Governor DeSantis fan ever since the Covid pandemic, when he governed Florida better than any other state in the union. That’s why Florida is the number one state for Americans who choose to move from one state to another. But the governor doesn’t seem to appreciate the downside of his position on importing drugs.

The WSJ editors explain: “Drug importation has gained support among Republicans who say Americans are subsidizing drugs for the rest of the world. There’s some truth in this. Drug prices in Canada are more than 50% lower than in the U.S. That’s largely because Canada’s government can compel manufacturers of patented drugs to reduce their prices. But Americans also get access to more innovative drugs, and sooner. Drugs were approved 468 days earlier in the U.S. than in Canada for the 218 medicines authorized in both countries between 2013 and 2019, according to the Fraser Institute.”

In other words, there is a tradeoff, a price to be paid, for allowing price controls in the U.S. just like they have in socialized countries like Canada. The price is less availability of drugs, longer waiting times, and less new drug innovations. This can be extremely important in situations like the Covid pandemic when new, life-saving drugs are being developed and brought to the marketplace.

WSJ says Trump could have used trade negotiations to prevent Canada and other countries with drug price controls from extorting American drug makers and “free-riding” on Americans. Instead, his Administration issued regulation on how states could obtain FDA approval to import drugs from Canada. Biden then followed with an executive order directing FDA to work with states that have proposed importation programs. Florida is the first to gain approval, but Texas, Colorado, and New Mexico are hoping to join in soon. Florida says its plan could save $150 million annually.

But this depends on no changes in the current system. Drug makers say they’ll reduce sales to Canada if their products will be exported to the U.S. Furthermore, Canada has warned it would restrict drug exports to the U.S. to prevent shortages. In other words, the supply of drugs in the U.S. imported from Canada is likely to be limited.

All of this is an attempt to import foreign drug price controls that the U.S. Congress won’t accept. But trying to get around the system this way only undermines and erodes U.S. intellectual property protections of the pharmaceutical industry that are necessary to reward the great cost of innovation and investment in drug research.

The old saying, “There’s no such thing as a free lunch” still applies.

Success at The Success Academy

For many years, it was widely believed that inner city black and brown students couldn’t compete with white students in school learning. Expectations were set low to give these students an excuse for underperforming in comparison to their white peers.

Then Eva Moskowitz, a former city council member, decided to challenge this conventional wisdom. She started a charter school in inner city Harlem New York where black and brown students had been failing for decades. Today, that charter school, and many others it spawned, is appropriately known as The Success Academy Charter School.

According to the New York Post, Success Academy had 17,700 applicants for 3,288 available seats, which resulted in a wait list of more than 14,000 families for the 2018–2019 school year.[7]The shortage of seats can be at least partly attributed to New York state educational policy. Robert Pondiscio, author of How The Other Half Learns (2019), which chronicles the structure and achievement of the Success Academy, believes that Moskowitz would quickly expand the system to 100 schools if the charter sector was not “hard up against the charter school cap in the State of New York”.

Two documentary films, The Lottery and Waiting for “Superman” record the intense desire of parents to enroll their children in Success Academy and charter schools like Success Academy.  By 2019, according to The Washington Post, the Success Academy network of 47 schools serving 17,000 students, is the “highest-performing and most criticized educational institution in New York”, and perhaps in the United States. Mayor Michael Bloomberg said that the Harlem Success Academy was “the poster child for this country.” President Barack Obama also recognized charter schools as being crucial in reforming the education system.

The latest evidence of the success of this charter school is documented in The Wall Street Journal. The editorial board says students are so eager and prepared to take the upcoming Advanced Placement (AP) exams – 1,317 of them – that the school has had to rent space in New York’s Javits Center. That’s the venue where they have events like the international auto show, where Hillary Clinton planned to have her presidential post-election celebration (that didn’t happen!), and where plans were made for handling the anticipated (but not needed) extra space to care for sick patients at the height of the Covid pandemic.

AP subjects range from chemistry and art history to biology and calculus, and some Success Academy students will sit for as many as five exams. The WSJ editors say, “Implicit in the rejection of testing now popular even at elite universities such as Harvard and Princeton is the idea that low-income children of color can’t succeed. The Success Academy student body is overwhelmingly black and Latino. But whether it’s the AP exams or the SATs, its students welcome standardized tests as an opportunity to prove what they have learned. Success knows that black and Latino children often lag behind their white peers. But it believes the answer is to bring their achievement up—rather than dumbing down or eliminating tests, which leaves them unprepared for college work.”

Is it working?

It seems to be working: U.S. News & World Report ranked Success’s Manhattan high school tied for first in the nation for college readiness, because 100% of seniors had passed at least one AP exam over their four years of high school.

“With rampant grade inflation and inconsistent state educational standards, AP and SAT tests are a critical tool in identifying students who are prepared for the rigors of college,” says Success Academy founder and CEO Eva Moskowitz. “This is especially true for low-income children of color. Attacking these tests does nothing except undermine the important work of helping disadvantaged students do better on these tests.”

Isn’t it great to read a good news story at least once in a while?

Rethinking Diabetes in 2024

Are you one of the 29.7 million Americans diagnosed with diabetes? Perhaps you are one of the 8.7 million Americans with undiagnosed diabetes? These statistics are probably underestimates since they were obtained in 2021 by the American Diabetes Association.

The truth is America is getting fatter and obesity often leads to diabetes. Recent estimates place 42% of Americans in the obese category. You may have noticed that advertisers for diabetes drugs now use obese actors and actresses to peddle their drugs. It seems they want to get the attention of the obese population since that’s the reality of many, though not all, diabetics.

Not surprisingly then, the prevalence of diabetes is increasing. The prevalence of diabetes in America grew from 6.3% in 2004 to 8.3% in 2021 according to the CDC. While obesity is a major risk factor for developing diabetes, family history, age, and race are also important risk factors. These statistics make it likely that one in 10 Americans has diabetes. The World Health Organization lists diabetes as the ninth leading cause of death worldwide.

What is the state of diabetes treatment today?

It has been more than 100 years since the miraculous discovery of insulin to treat diabetes. A lot of progress has been made since then, but there is still much more progress to be made. If you’re a diabetic, or know someone in your family who is, you’ll probably be interested in a new book called Rethinking Diabetes by Gary Taubes. I have not read the book, but I have read a review of the book published in The Wall Street Journal by James S. Hirsch.

Mr. Hirsch, a diabetic himself who has also written books about diabetes, has a unique perspective for reviewing this new book. He says if any disease needs to be rethought, it is surely diabetes, and that is the premise of Gary Taubes’s latest book. A veteran science journalist who has now written five books on the relationship between diet and chronic disease, Mr. Taubes is not interested in the many other factors that undermine diabetic health, including access to care and the affordability of therapies. Instead, he offers a unified theory on why patient outcomes are lagging. The key is food, specifically our overreliance on carbohydrates.

Mr. Hirsch says, “Mr. Taubes believes that diabetes is a cautionary tale for “the medicalization of modern life,” which unduly emphasizes pharmacology over diet and nutrition. We’d be much healthier, he argues, if we ate better and took fewer drugs. Whatever the practical limits of that goal—and I have my doubts—Mr. Taubes’s message is important and should be heard.”

Hirsch goes on to tell us Taubes makes a convincing case that dietary fat has been given a bad rap since even before the insulin era began in 1921. Dr. Elliott Joslin, America’s leading diabetologist in the first half of the 20th century, was among those who believe that dietary fat either caused diabetes or made its complications worse. He believed that once insulin was discovered, its goal was to allow patients to increase their consumption of carbohydrates – which include such staples as bread, potatoes, and fruit – without sugar appearing in the urine.

The “demonization” of fat, Mr. Taubes writes, would only intensify in the decades to come as it was linked to heart disease, leading the ADA and other health organizations to prescribe diabetic diets high in carbohydrates and low in fat.  But this approach has been discredited recently with respect to heart disease. The American Heart Association no longer recommends the low-fat diet as a solution to heart disease.

The problem is that carbohydrates increase your blood sugar, and elevated blood sugar—hyperglycemia—is exactly what people with diabetes are trying to avoid. The latest tactic now takes the opposite approach – low carbohydrates. This approach is advocated by Dr. Richard Bernstein, an engineer-turned-doctor who also has Type I diabetes. In the 1970s, he became the first person to use a home glucose meter; looking at his data, he realized that a low-carb diet minimized his glycemic swings. For the past 40 years, in his books, academic papers and other advocacy, he has been the leading low-carb evangelist for people with diabetes.

Mr. Taubes’s larger point is that we have allowed pharmacological miracles in the treatment of diabetes, insulin being one of them, to supplant food and nutrition as the foundation of good health. He concurs with Dr. Arnoldo Cantani, a 19th-century Italian physician, who said that the remedy for diabetes “is not in the drugstore but in the kitchen.”

Though I am not a diabetic, I certainly concur with those who advocate diet, exercise, and weight control over a pharmaceutical panacea that seems to gloss over these fundamentally important tenants of good health. America needs to lose more weight, not take more drugs.